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Abstract
Background: The study was aimed to identify pre- and intraoperative risk factors that potentially
influence morbidity and mortality after esophagectomy for esophageal carcinoma with particular
emphasis on the predominant tumor types.
Patients and methods: Between September 1985 and March 2004, 424 patients underwent
esophagectomy for esophageal carcinoma. Of these, 186 (43.9%) patients had a transhiatal, and 231
(54.5%) patients underwent a transthoracic procedure with two-field lymphadenectomy. Pre-,
intraoperative risk factors and tumor characteristics were included in the risk analysis to assess
their influence on postoperative morbidity and mortality.
Results: Multivariate analysis (logistic regression model) identified the surgical procedure as the
most important risk factor for postoperative morbidity and mortality with the transthoracic
technique associated with a significant higher risk. The comparison of the risk profile between the
different histological tumor types, a significantly higher nutritional risk, poorer preoperative lung
function and a higher prevalence of hepatopathy was observed in patients with squamous cell
carcinoma (n = 229) compared to adenocarcinoma (n = 150) (p < 0.05). Although there was no
significant difference in surgical complications between the two groups, the rate of general
complications, length of postoperative intensive care unit-stay and mortality rate was significantly
higher in patients with squamous cell carcinoma (p < 0.05).
Conclusion: The present risk analysis shows that the selection and the type of the surgical
procedure are crucial factors for both the incidence of postoperative complications and the
mortality rate. The higher risk of the transthoracic procedure is justified with a view to a better
long term prognosis.
Background
Despite the standardization of the operative technique,
improvement of preoperative risk assessment, and post-
operative intensive care management, surgical therapy for
esophageal carcinoma continues to be associated with a
high incidence of operative complications, and a high
mortality rate. Risk stratification in the selection of
patients for surgery, and the choice of the surgical proce-
dure are therefore important considerations.
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The present study was aimed to identify preoperative and
intraoperative factors that could potentially influence
morbidity and mortality after esophagectomy for esopha-
geal carcinoma.
Patients and methods
Between September 1985 and March 2004, a total of 424
patients underwent esophagectomy for esophageal carci-
noma in the Department of General and Abdominal Sur-
gery of the Johannes Gutenberg-University Hospital
Mainz. Of these, 186 (43.9%) patients had transhiatal
esophagectomy, 231 (54.5%) patients underwent abdom-
inothoracic esophagectomy with two-field lymphadenec-
tomy (abdominal and mediastinal) and 7 patients had a
proximal esophageal resection with a free jejunal graft.
Reconstruction was accomplished by gastric tube pull-up
in 384 (93.0%) patients, by colon interposition in 21
(5.1%), and small intestine interposition in 7 (1.7%)
patients; the anatomic prevertebral esophageal bed was
used for the majority of these procedures. Extra-anatomic
reconstruction by the retrosternal route with cervical anas-
tomosis after pull-up was carried out in patients with a
high risk for loco-regional recurrence only (n = 42;
10.2%).
Abdominothoracic esophagectomy was routinely per-
formed for squamous cell carcinoma (n = 229). A transhi-
atal procedure was selected for tumors with a distal
location, for malignancies without esophageal wall pene-
tration, or in the presence of a high general risk. Transhi-
atal esophagectomy with abdominal and posterior
mediastinal lymphadenectomy was carried out for the
majority of adenocarcinomas (n = 150), the two-field pro-
cedure was performed in the presence of advanced tumor
growth or extended lymph node involvement. Long-term
results of this choice of the operative procedure adjusted
to the histological tumor type had shown a significant
prognostic advantage in patients undergoing transtho-
racic compared to transhiatal resection in squamous cell
carcinoma whereas there was no survival benefit in
patients with adenocarcinoma of the esophagus [Jungin-
ger T, et al.; Gockel I et al.; unpublished data].
Data were collected prospectively in a specially estab-
lished database. Preoperative and intraoperative variables
as well as postoperative morbidity and mortality were
documented, in addition to routine demographic data.
The following preoperative risk factors were recorded:
ASA-classification (I-IV) according to the preoperative
anesthesiology evaluation, BMI (Body Mass Index) based
on body weight and height in kg/m2, and the nutritional
status on a scale from 0 (= no alcohol or tobacco con-
sumption), 1 (= tobacco alone), 2 (alcohol alone) to 3 (=
combined nutritional risk with tobacco and alcohol use).
Among the preoperative diseases, cardiovascular risk fac-
tors were defined as a history of coronary heart disease, or
myocardial infarction, arterial hypertension, valvular dis-
ease (>II°), arrhythmia requiring therapy (>III° according
to the Lown-classification), congestive heart failure NYHA
(New York Heart Association) > Grade II, and peripheral
occlusive arterial disease (>IIb according to Fontaine). A
history of chronic obstructive pulmonary disease
(COPD), regular tobacco consumption and/or the use of
bronchodilators were subsumed under pulmonary dis-
eases. The preoperative assessment of the vital capacity
(VC) and forced expiratory volume (FEV1 = Tiffeneau-test)
served to ensure a more accurate assessment. Prior cirrho-
sis of the liver (>/= CHILD-Pugh A) was defined as hepatic
disease, and determined on the basis of the assessment of
serum albumin (g/dl), serum bilirubin (mg/dl), Quick-
value (%), and the presence of ascites or encephalopathy.
The evaluation of additional risk factors included the
prevalence of diabetes mellitus (insulin-dependent or
requiring oral antidiabetic therapy), and the history of a
secondary carcinoma.
Intraoperative variables included in the risk analysis were
tumor location, the operative procedure, and the transfu-
sion requirement of packed erythrocytes. The group of
tumor characteristics comprised tumor size, R-classifica-
tion, TNM-stage, and the number of dissected lymph
nodes.
Postoperative variables were not part of this risk analysis.
Morbidity, surgical (anastomotic leakage, graft necrosis,
mediastinitis, recurrent laryngeal nerve paralysis, chylot-
horax, tracheal fistula, bleeding requiring reoperation)
and general complications (pneumonia, atelectasis, ARDS
i.e. adult respiratory distress syndrome, myocardial infarc-
tion, cardiac failure, pulmonary embolism, renal insuffi-
ciency, pancreatitis, deep vein thrombosis), length of
intensive care unit stay, 30-day mortality, and the mortal-
ity rate served as factors for assessment.
Statistical analysis
The SSPS 10.0 software package was used for statistical
data analysis (SSPS, Chicago, IL, USA: 1999). Data are
expressed as median with ranges (minimum – maxi-
mum), or as percentages (%).
Factors with a possible influence on perioperative mor-
bidity and mortality were calculated using the logistic
regression model (univariate and multivariate). The χ 2
test with Pearson's correction and Fisher's exact test were
used for comparison of the parameters for squamous cell
carcinoma and adenocarcinoma. The Mann-Whitney U
test served as the non-parametric method. A p -value of
<0.05 was considered statistically significant for all
procedures.World Journal of Surgical Oncology 2005, 3:37 http://www.wjso.com/content/3/1/37
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Results
Preoperative and intraoperative parameters, tumor 
characteristics
Median patient age at the time of surgery was 58 (28–84)
years; the proportion of males was 83.0%. The median
BMI (Body Mass Index) was 24.4 (13.8–39.3) kg/m2. A
total of 36.9% patients were classified as ASA grade II,
58.2% as ASA grade III, and 4.9% as ASA grade IV. A com-
bined nutritional risk (alcohol and tobacco use) was
determined in 41.5% of patients. Tobacco use alone was
found in 59.1%, and habitual alcohol consumption in
58.2% of patients. Preexisting cardiovascular diseases
were noted in 28.2%, pulmonary disease in 13.5%, hepat-
opathy in 4.9%, and diabetes mellitus in 5.9% of patients
undergoing surgery for esophageal carcinoma. The history
of 9.8% of all patients showed the presence of secondary
carcinoma. Median preoperative vital capacity (VC)
ranged at 3.8 (1–7.2) l, FEV1 (Tiffeneau-test) was 2.9 (0.5–
9.0) l/sec.
Out of all tumors, 56.3% were located in the lower, 34.6%
in the middle, and 9.1% in the upper third of the esopha-
gus. Squamous cell carcinoma was identified in 55.3%,
adenocarcinoma in 35.9%, and an undifferentiated carci-
noma in 7.6% of patients (1.2% with other malignant
esophageal tumors, e.g. melanoma) who underwent
esophagectomy.
Operative time ranged at 300 (160–560) minutes. The
median number of packed erythrocyte units used was 1
(0–38) (54.6% of all patients did not require packed
erythrocyte transfusion). Median length of intensive care
therapy was 10 (0–176) days, at a total postoperative hos-
pital stay of 22 (0–189) days. Median tumor size was 4
(0.3–20) cm. A R0 resection was accomplished in 81.0%
of all patients (R1 resection: 16.0%, R2 resection: 3.0%).
Based on results of the pathological examination, the
majority of tumors were assigned to the T3 category
(57.5%), while 34.6% of all tumors were allocated to the
T1 or T2, and 7.9% to the T4-category. Distribution for the
N category was as follows: N0: 34.0%, N1: 66.0%. A M1-
situation (M1-lymph node or M1-organ) was identified in
26.5% of all patients, which was treated with curative
intent in the course of the same surgical procedure.
Morbidity and mortality: Prevalence and influence factors
There was a 35.5% prevalence of surgical complications in
the total population of 424 patients undergoing
esophagectomy for esophageal carcinoma. General com-
plications were observed in 36.0% of all patients. The 30-
day mortality rate was 6.7%, at a mortality rate for the
entire observation period of 11.5%.
Anastomotic leakage was the most common surgical com-
plication (18.2%), followed by recurrent laryngeal nerve
paresis (15.7%). There was a similar incidence of graft
necrosis (3.2%) and postoperative hemorrhage (2.9%)
requiring surgical revision, while 1.3% of all patients
developed a chylothorax.
Univariate analysis showed tumor location (p = 0.0194)
and the surgical procedure (p = 0.0116) to be significantly
related to the incidence of surgical complications; none of
the other pre- and intraoperative factors, including tumor
characteristics, were of relevance in this model (Table 1).
Multivariate analysis identified the transthoracic surgical
procedure (p = 0.0004), tumor location (upper third) (p
= 0.02), and the transfusion of packed erythrocytes (p =
0.04) as factors significantly related to the incidence of
surgical complications (Table 2).
Pulmonary complications were most common among the
general complications (32.9%). Adult respiratory distress
syndrome (ARDS) occurred in 6.5% of patients. Postoper-
atively, 3.7% of patients developed renal failure requiring
dialysis, and myocardial infarction or pulmonary embo-
lism occurred in 1.2%, respectively, of all patients. Post-
operative pancreatitis was found in 0.5% of patients.
Univariate analysis determined patient age (p = 0.0073),
ASA-classification (p = 0.0076), preexisting cardiovascular
(p = 0.0171), pulmonary (p = 0.0405), and hepatic (p =
0.0282) disease as significant preoperative variables in
relation to postoperative general complications. Similarly
significant among the intraoperative factors were tumor
location (p = 0.0156), the surgical procedure (p =
0.0001), transfusion of packed erythrocytes, as well as the
T-category in the group of tumor characteristics (Table 1).
On multivariate analysis, independent parameters with a
significant influence on postoperative general complica-
tions were in decreasing order: the surgical procedure (p =
0.0001), transfusion of packed erythrocytes (p = 0.0009),
patient age (p = 0.0039), nutritional status (p = 0.0284),
and ASA-classification (p = 0.0486) (Table 2).
The cause of postoperative mortality (11.5%; n = 49
patients) in 19 patients was sepsis (accounted for by anas-
tomotic insufficiency in 8, and in 3 patients by graft necro-
sis). Twelve patients died from pulmonary failure, and 5
patients died after myocardial infarction. Fulminant pul-
monary embolism was the cause of death in 3 patients
(one out of these occurred in a patient with suture dehis-
cence). Two patients developed hemorrhagic shock, and
another 2 patients died in hospital from rapid progression
of the malignant disease. Further causes of hospital death
in 6 additional patients after esophagectomy were; hepa-
torenal syndrome, syncopal attack with cardiovascular
failure, right ventricular heard failure, medial cerebral inf-
arction, intraoperative cardiac arrest, and tracheogastric
fistula.World Journal of Surgical Oncology 2005, 3:37 http://www.wjso.com/content/3/1/37
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Preoperative variables as predictors of a fatal postopera-
tive course found on univariate analysis comprised ASA-
classification (p = 0.0274), preexisting cardiovascular (p =
0.0172) and pulmonary disease (p = 0.0059), and hepat-
opathy (p = 0.0165). Further factors exerting an influence
on mortality were: tumor location (p = 0.0391), the
surgical procedure (p = 0.0057), packed erythrocyte trans-
fusion (p = 0.0022), R-classification (p = 0.0439), and T-
category (p = 0.0036) (Table 1). Multivariate analysis
identified the surgical procedure (p = 0.0068), preexisting
pulmonary disease (p = 0.0096), and the transfusion of
packed erythrocytes (p = 0.0099) as the most significant
predictors of mortality (Table 2).
Risk profile: comparison between squamous cell 
carcinoma and adenocarcinoma
From among the group of preoperative factors, patients
with adenocarcinoma were characterized by significantly
more advanced age and a higher BMI (p < 0.0001)
compared to those with squamous cell carcinoma. Differ-
ences in gender distribution and ASA-classification were
not significant. There was a significantly higher nutri-
tional risk (alcohol and tobacco use) in patients with
squamous cell carcinoma than in the comparison group
of patients with adenocarcinoma undergoing esophagec-
tomy (p < 0.001). The incidence of cardiovascular and
pulmonary disease, as well as preexisting diabetes melli-
tus, or secondary carcinoma in the patient history was
similar in both groups. However, patients with squamous
Table 1: Factors with a potential influence on surgical and general complications, as well as on the perioperative mortality rate after 
esophagectomy for esophageal carcinoma: univariate analysis (p values).
Surgical complications General Complications Perioperative Mortality
Preoperative factors:
- Age 0.8996 0.0073* 0.1349
- Sex 0.7367 0.3396 0.5658
- BMI 0.3710 0.1200 0.0719
- ASA 0.3992 0.0076* 0.0274*
- Nutritional status 0.5093 0.1897 0.2223
- Cardiovascular PD 0.7803 0.0171* 0.0172*
- Pulmonary PD 0.2910 0.0405* 0.0059*
- Hepatopathy 0.1696 0.0282* 0.0165*
- Diabetes mellitus 0.8218 0.0635 0.9430
Intraoperative factors:
- Tumor location 0.0194* 0.0156* 0.0391*
- Surgical procedure 0.0116* 0.0001* 0.0057*
- Packed erythrocyte transfusion 0.1045 0.0006* 0.0022*
Tumor characteristics:
- Tumor size 0.5041 0.1595 0.1502
- R-classification 0.5573 0.3372 0.0439*
- T-category 0.2017 0.0072* 0.0036*
- N-category 0.6805 0.9928 0.0584
- M-category 0.0621 0.8128 0.4359
*statistically significant
Table 2: Significant factors with a potential influence on surgical and general complications, as well as on the perioperative mortality 
rate after esophagectomy for esophageal carcinoma: multivariate analysis (p value).
Surgical complications General complications Perioperative Mortality
Surgical procedure (p = 0.0004) Surgical procedure (p = 0.0001) Surgical procedure (p = 0.0068)
Tumor location (p = 0.0204) Packed erythrocyte transfusion (p = 0.0009) Pulmonary PD (p = 0.0096)
Packed erythrocyte transfusion (p = 0.0493) Patient age (p = 0.0039) Packed erythrocyte transfusion (p = 0.0099)
Nutritional status (p = 0.0284)
ASA-classification (p = 0.0486)World Journal of Surgical Oncology 2005, 3:37 http://www.wjso.com/content/3/1/37
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cell carcinoma had significantly poorer preoperative lung
function (p = 0.0078), and a higher prevalence of hepat-
opathy (p < 0.0001) (Table 3).
The surgical procedure used was different with respect to
the significantly more frequent performance of transhiatal
esophagectomy in patients with adenocarcinoma (p <
0.0001). In the presence of this histological subtype, the
gastric tube (p = 0.027) brought up in the existing esopha-
geal bed (p = 0.001) was used more often as the inter-
posed organ. The number of dissected abdominal lymph
nodes was significantly higher (p = 0.0146) for adenocar-
cinoma, while a significantly higher number of thoracic
lymph nodes (p = 0.0011) was removed in patients with
squamous cell carcinoma. The operative time was signifi-
cantly shorter (p < 0.0001) at a lower packed erythrocyte
transfusion requirement for adenocarcinoma (p =
0.0495) compared to squamous cell carcinoma (Table 4).
There was no significant difference between the two
groups with regard to UICC stages and tumor characteris-
tics (p > 0.05).
Although there was no significant difference in surgical
complications between the two groups, the rate of general
complications (p = 0.012), and thus the total complica-
tion rate, (p = 0.039) was significantly higher in patients
with squamous cell carcinoma. Comparable to the mor-
bidity rate, the duration of postoperative intensive care
therapy was significantly longer (p < 0.0001) for this type
of tumor than for adenocarcinoma.
Table 3: Comparison of the preoperative risk profile between patients with squamous cell carcinoma and adenocarcinoma of the 
esophagus.
Parameter Squamous cell carcinoma (n = 229) Adenocarcinoma (n = 150) p-value
- Age (years) 56.0 (29–84) 61.0 (28–78) 0.0001*
- Sex (% males) 79.8 87.4 0.071
- BMI (kg/m2) 23.2 (13.9–34.9) 25.8 (15.8–39.3) 0.0001*
- ASA-classification (%)
-II 33.2 43.2
-III 62.4 52.1 0.072
-IV 4.4 4.8
- Nutritional risk (%)
-No nutritional risk (%) 16.2 43.2 0.0001*
-Alcohol use (%) 69.5 42.9 0.0001*
-Tobacco use (%) 73.5 38.1 0.0001*
-Combined risk (%) 83.8 56.9 0.0001*
- Cardiovascular PD (%) 30.4 24.7 0.240
- Pulmonary PD (%) 14.7 14.4 0.593
-VC (l) 3.7 (1.0–6.6) 3.8 (1.9–6.1) 0.3063
-FEV 1 (l/sec) 2.8 (0.5–5.2) 3.1 (1.3–5.9) 0.0078*
- Hepatopathy (%) 8.1 1.4 0.0001*
- Diabetes mellitus (%) 4.9 7.5 0.369
- Secondary carcinoma (%) 11.2 8.2 0.382
*statistically significant
Table 4: Intraoperative Factors: Comparison between squamous cell carcinoma and adenocarcinoma of the esophagus.
parameter Squamous cell carcinoma (n = 229) Adenocarcinoma (n = 150) p-value
- Surgical procedure (% transhiatal) 30.6 68.7 0.0001*
- Esophageal substitute (% gastric tube) 90.8 97.3 0.027*
- Repositioning (% esophageal bed) 83.7 95.3 0.001*
- Number of removed abdominal LN (n) 11 (0–55) 13 (0–51) 0.0146*
- Number of removed thoracic LN (n) 11 (0–47) 6 (0–83) 0.0011*
- Operative time (min) 305 (115–560) 270 (160–540) 0.0001*
- Intraoperative blood loss (ml) 1000 (200–5000) 800 (0–7500) 0.2224
- Units of transfused packed erythrocytes (n) 1.5 (0–38) 0 (0–14) 0.0495*
*statistically significantWorld Journal of Surgical Oncology 2005, 3:37 http://www.wjso.com/content/3/1/37
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The 30-day mortality rate was identical for both groups,
while the mortality rate in patients with squamous cell
carcinoma was significantly higher (p < 0.0001) (Table 5).
Discussion
Although the morbidity rate after esophagectomy for
esophageal carcinoma has been markedly reduced in
recent years as a result of improvements in patient selec-
tion, surgical technique, and advances in perioperative
management, the morbidity rate remains high [1-7].
Pulmonary function disturbances are the major contribut-
ing factor here [8-10]. Risk factors for the development of
impaired pulmonary function include smoking, patient
age (>70 years), obesity, and preexisting COPD [11].
Parameters with an influence on perioperative mortality
defined by Bartels et al , are in decreasing order: reduced
general status of the patient, impaired cardiac and hepatic
function, and respiratory function [12]. The evaluation of
the preoperative function of the described organ systems
using a scoring system developed by the authors enables
the classification of risk groups, and leads to a decrease in
the operative risk as a result of adequate patient selection
[12].
The aim of our analysis of data collected prospectively in
424 patients undergoing surgery for esophageal carci-
noma was to answer the question as to what extent the
selection of the surgical procedure, i.e. the transthoracic or
the transhiatal approach, and the operative course
assessed on the basis of intraoperative blood loss, in addi-
tion to patient and tumor related factors, exert an influ-
ence on the postoperative course.
The data were collected in 424 consecutive patients under-
going surgery for esophageal carcinoma over the period
from 1985 to 2004. Surgical complications occurred in
35.5% and general complications in 36.0% of patients.
The 30-day mortality rate ranged at 6.7%, at a mortality
rate of 11.5%. Univariate analysis identified the selection
of the surgical procedure as the main risk factor affecting
the mortality rate. Transthoracic esophagectomy was asso-
ciated with a higher complication and mortality rate than
transhiatal dissection. Various authors have investigated
the question as to the effectiveness of an extended radical
procedure with an associated increased operative risk after
the transthoracic technique. Results of two randomized
studies did not demonstrate a difference between these
procedures, although the meaningfulness of these
findings is limited due to the small number of patients
enrolled and the lack of information on the oncological
radicality, especially the extent of lymph node dissection
[13,14]. In addition, only patients with early tumor stages
[14] or with a distal location of the carcinoma [13] were
taken into consideration, respectively.
A higher pulmonary complication rate after the transtho-
racic compared to the transhiatal procedure for adenocar-
cinoma was found by a prospective randomized study
[15]. Postoperative ventilation time, intensive care unit
and postoperative in-hospital stay, reflecting
perioperative morbidity, were significantly longer after
transthoracic in contrast to transhiatal esophagectomy in
this trial. However, the authors did not determine any dif-
ferences in the long-term course [15]. This prospective
study confirmed the outcome of a meta analysis revealing
significantly higher early (pulmonary) morbidity and
mortality after the transthoracic procedure published pre-
viously by the same author with 5-year survival rates of
approximately 20% after both kinds of resection [16]. In
our patient population, the long-term prognosis for
patients with squamous cell carcinoma undergoing tran-
sthoracic surgery – though exhibiting a higher periopera-
tive morbidity and mortality – was significantly better
than that for patients after transhiatal resection [Junginger
T, et al.; unpublished data]. Patients with adenocarci-
noma did not differ in survival undergoing transhiatal or
transthoracic esophagectomy [Gockel I, et al; unpublished
data]. In concert with other authors, we therefore favor the
transhiatal technique with posterior mediastinal and
upper abdominal lymph node dissection for adenocarci-
Table 5: Postoperative morbidity and mortality for squamous cell carcinoma compared with adenocarcinoma of the esophagus.
parameter Squamous cell carcinoma (n = 229) Adenocarcinoma (n = 150) p-value
- Surgical complications (%)
- General complications (%) 37.9 33.7 0.447
-Total complications (%) 40.7 28.0 0.012*
- Length of ICU – stay (d) 68.1 57.6 0.039*
- 30-day-moratlity (%)
- Mortality (%) 11 (2–176) 8 (1–107) 0.0001*
6.1 6.1 0.8569
15.1 6.6 0.0001*
*statistically significantWorld Journal of Surgical Oncology 2005, 3:37 http://www.wjso.com/content/3/1/37
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noma of the esophagus, and the transthoracic procedure
with abdominal and mediastinal lymphadenectomy for
squamous cell carcinoma. Thus – long term results regard-
ing the surgical technique of our own patient population
have to be viewed critically, especially for adenocarci-
noma, as the two groups differed significantly in UICC-
stage and R-classification in contrast to patients with
squamous cell carcinoma with a rather equal distribution
[1,2].
Independent of the operative procedure, surgical blood
loss had a significant influence on the postoperative mor-
bidity and mortality rates. This is in accordance with expe-
riences reported by Whooley et al [8], and indicates that
the selection of a limited resection technique can be cru-
cial for the development of the postoperative course.
Patient-associated parameters (age, nutritional status,
ASA-classification) were of relevance only with respect to
the occurrence of general complications.
Preexisting pulmonary disease was an independent pre-
dictor of postoperative mortality. This confirms the find-
ings of Chan et al , who identified impaired pulmonary
function as a preoperative variable predictive of postoper-
ative mortality [17]. The implementation of an appropri-
ate preoperative therapy, discontinuation of smoking,
more frequent use of epidural analgesia, and early bron-
choscopy in the presence of the suspicion of postoperative
pulmonary secretion impairment are essential factors for
risk reduction [8].
In contrast to results of risk analyses by Law et al [18] and
Lund et al [19], tumor characteristics as, e.g. TNM classifi-
cation, were of no influence on the postoperative course
in the patient population of this study.
A different operative risk was determined for the two his-
tological tumor types of the esophagus: while there were
similar surgical complications in both groups, overall
morbidity and mortality rates were significantly higher in
patients with squamous cell carcinoma than in the group
with adenocarcinoma. In accordance with reports in the
literature [20-22], this reflects, on the one hand, the differ-
ent preoperative risk profile of both entities, consisting of
an increased nutritional risk, higher prevalence of hepat-
opathy, and poorer lung function in patients with squa-
mous cell carcinoma. Additionally, in this study there was
a significantly higher incidence of transthoracic
esophagectomy with a higher complication rate in
patients with squamous cell carcinoma than in those with
adenocarcinoma (69.4 vs. 31.3%).
Conclusion
The present analysis shows that the selection and the type
of the surgical procedure are crucial factors for both the
incidence of postoperative complications and the mortal-
ity rate. The transhiatal procedure is associated with a sig-
nificantly lower morbidity and mortality rate and thus
represents – as long term survival does not favor the tran-
sthoracic approach – the surgical technique of choice for
adenocarcinoma of the esophagus. In contrast, our previ-
ous long-term experience and results obtained by this
study advocate the performance of the transthoracic pro-
cedure for squamous cell carcinoma. The higher operative
risk is justified with a view to a better long-term prognosis.
Independent of the choice of the operative approach, a
less-invasive surgical procedure and the implementation
of measures designed to minimize the risk of pulmonary
complications are essential to achieve a reduction in the
morbidity rate of esophageal carcinoma.
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